Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2010 (Vol. 30, No. 4)

National Institute of Biomedical Imaging and Bioengineering

URL:www.nibib.nih.gov
  • Nice collection of links, nice image/video galleries
  • Nothing major

It seems that I am always stumbling upon new NIH institutes. (I prefer to stumble, rather than to simply go to the NIH’s website and learn about all 27 centers and institutes at once—where’s the fun in that?) The website for the National Institute of Biomedical Imaging and Bioengineering (NIBIB) offers visitors a number of valuable resources. There are, of course, the usual research, funding, and training tabs to describe opportunities within the institute, but there are also other links of interest. Under the health and education tab, one can find an assortment of links indexed under the headings Science Education and Resource Library. Definitely, though, my favorite portions of the website are the image and video galleries. These galleries showcase the research of institute scientists and are a must-see for any visitor to the site.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »